Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41467-018-05368-1.

Title:
Genomic instability in mutant p53 cancer cells upon entotic engulfment | Nature Communications
Description:
Cell-in-cell (CIC) structures are commonly seen in tumours. Their biological significance remains unclear, although they have been associated with more aggressive tumours. Here we report that mutant p53 promotes CIC via live cell engulfment. Engulfed cells physically interfere in cell divisions of host cells and for cells without p53 this leads to host cell death. In contrast, mutant p53 host cells survive, display aberrant divisions, multinucleation and tripolar mitoses. In xenograft studies, CIC-rich p53 mutant/null co-cultures show enhanced tumour growth. Furthermore, our results show that CIC is common within lung adenocarcinomas, is an independent predictor of poor outcome and disease recurrence, is associated with mutant p53 expression and correlated to measures of heterogeneity and genomic instability. These findings suggest that pro-tumorigenic entotic engulfment activity is associated with mutant p53 expression, and the two combined are a key factor in genomic instability. Cell-in-cell (CIC) structures are frequently observed in cancers; however, it is unclear how their formation contributes to tumorigenesis. Here, the authors show that the high frequency of CIC is linked to mutant p53 status and CIC containing p53 mutant cancer cells are pro-tumorigenic due to enhanced genomic instability.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,555,829 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$536,300 per month
Our estimates place Nature.com's monthly online earnings from display ads at $357,511 to $983,155.

Keywords {🔍}

cells, cell, cic, mutant, fig, pubmed, engulfment, article, cancer, google, scholar, supplementary, tumour, lung, cas, structures, tumours, entotic, expression, mice, host, number, engulfing, nature, null, genomic, death, data, adenocarcinoma, experiments, division, events, growth, movie, bar, stained, central, tripolar, study, scale, bars, status, left, red, sem, cocultures, observed, size, lines, images,

Topics {✒️}

nature portfolio privacy policy biomedical services crispr construct plv-u6g-epcg advertising cancer research uk john le quesne & patricia reprints cic-rich p53 mutant/null nature 511 nature 502 nature 545 nature 501 nature library supplementary movie 1 supplementary movie 2 supplementary movie 3 supplementary movie 4 supplementary movie 5 supplementary movie 6 supplementary movie 7 supplementary movie 8 supplementary movie 9 john le quesne high-risk invasive patterns mariam jamal-hanjani smooth/mild/moderate/severe european genome–phenome archive fresh media added research focusing treatment-resistant subclones resulting 5-arylamino-2h-pyrazol-3-yl grant number c11496/a17786 mutant p53/p53 null overcomes growth arrest/senescence epithelial-rich viable malignancy mutant p53-independent manner small-cell lung cancer �moon-shape’ host nucleus original author parametric mann–whitney test parametric kruskal–wallis test mutant p53-positive cells specifically detect p-chk1 k-ras12d activating mutation permissions wilcoxon rank-sum test high-risk histological patterns alphav-class integrins cooperate

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Genomic instability in mutant p53 cancer cells upon entotic engulfment
         description:Cell-in-cell (CIC) structures are commonly seen in tumours. Their biological significance remains unclear, although they have been associated with more aggressive tumours. Here we report that mutant p53 promotes CIC via live cell engulfment. Engulfed cells physically interfere in cell divisions of host cells and for cells without p53 this leads to host cell death. In contrast, mutant p53 host cells survive, display aberrant divisions, multinucleation and tripolar mitoses. In xenograft studies, CIC-rich p53 mutant/null co-cultures show enhanced tumour growth. Furthermore, our results show that CIC is common within lung adenocarcinomas, is an independent predictor of poor outcome and disease recurrence, is associated with mutant p53 expression and correlated to measures of heterogeneity and genomic instability. These findings suggest that pro-tumorigenic entotic engulfment activity is associated with mutant p53 expression, and the two combined are a key factor in genomic instability. Cell-in-cell (CIC) structures are frequently observed in cancers; however, it is unclear how their formation contributes to tumorigenesis. Here, the authors show that the high frequency of CIC is linked to mutant p53 status and CIC containing p53 mutant cancer cells are pro-tumorigenic due to enhanced genomic instability.
         datePublished:2018-08-03T00:00:00Z
         dateModified:2018-08-28T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41467-018-05368-1
         keywords:
            Cell biology
            Non-small-cell lung cancer
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig7_HTML.png
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hannah L. Mackay
               affiliation:
                     name:MRC Toxicology Unit
                     address:
                        name:MRC Toxicology Unit, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Birmingham
                     address:
                        name:Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Moore
               affiliation:
                     name:MRC Toxicology Unit
                     address:
                        name:MRC Toxicology Unit, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Leicester
                     address:
                        name:Cancer studies, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Callum Hall
               affiliation:
                     name:Cancer Research UK Manchester Institute
                     address:
                        name:Cancer Research UK Manchester Institute, Manchester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nicolai J. Birkbak
               affiliation:
                     name:The Francis Crick Institute
                     address:
                        name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
                        type:PostalAddress
                     type:Organization
                     name:University College London Cancer Institute
                     address:
                        name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mariam Jamal-Hanjani
               affiliation:
                     name:University College London Hospitals
                     address:
                        name:Department of Medical Oncology, University College London Hospitals, London, UK
                        type:PostalAddress
                     type:Organization
                     name:Garscube Estate
                     address:
                        name:CRUK The Beatson Institute, Garscube Estate, Glasgow, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Saadia A. Karim
               affiliation:
                     name: University of Glasgow
                     address:
                        name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vinaya M. Phatak
               affiliation:
                     name:MRC Toxicology Unit
                     address:
                        name:MRC Toxicology Unit, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lucia Piñon
               affiliation:
                     name:MRC Toxicology Unit
                     address:
                        name:MRC Toxicology Unit, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jennifer P. Morton
               affiliation:
                     name: University of Glasgow
                     address:
                        name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
                        type:PostalAddress
                     type:Organization
                     name:University Hospitals Leicester NHS Trust
                     address:
                        name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Charles Swanton
               affiliation:
                     name:The Francis Crick Institute
                     address:
                        name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
                        type:PostalAddress
                     type:Organization
                     name:University College London Cancer Institute
                     address:
                        name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
                        type:PostalAddress
                     type:Organization
                     name:University College London Hospitals
                     address:
                        name:Department of Medical Oncology, University College London Hospitals, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John Le Quesne
               affiliation:
                     name:MRC Toxicology Unit
                     address:
                        name:MRC Toxicology Unit, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Leicester
                     address:
                        name:Cancer studies, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University Hospitals Leicester NHS Trust
                     address:
                        name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Patricia A. J. Muller
               affiliation:
                     name:MRC Toxicology Unit
                     address:
                        name:MRC Toxicology Unit, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:Cancer Research UK Manchester Institute
                     address:
                        name:Cancer Research UK Manchester Institute, Manchester, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Genomic instability in mutant p53 cancer cells upon entotic engulfment
      description:Cell-in-cell (CIC) structures are commonly seen in tumours. Their biological significance remains unclear, although they have been associated with more aggressive tumours. Here we report that mutant p53 promotes CIC via live cell engulfment. Engulfed cells physically interfere in cell divisions of host cells and for cells without p53 this leads to host cell death. In contrast, mutant p53 host cells survive, display aberrant divisions, multinucleation and tripolar mitoses. In xenograft studies, CIC-rich p53 mutant/null co-cultures show enhanced tumour growth. Furthermore, our results show that CIC is common within lung adenocarcinomas, is an independent predictor of poor outcome and disease recurrence, is associated with mutant p53 expression and correlated to measures of heterogeneity and genomic instability. These findings suggest that pro-tumorigenic entotic engulfment activity is associated with mutant p53 expression, and the two combined are a key factor in genomic instability. Cell-in-cell (CIC) structures are frequently observed in cancers; however, it is unclear how their formation contributes to tumorigenesis. Here, the authors show that the high frequency of CIC is linked to mutant p53 status and CIC containing p53 mutant cancer cells are pro-tumorigenic due to enhanced genomic instability.
      datePublished:2018-08-03T00:00:00Z
      dateModified:2018-08-28T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41467-018-05368-1
      keywords:
         Cell biology
         Non-small-cell lung cancer
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05368-1/MediaObjects/41467_2018_5368_Fig7_HTML.png
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hannah L. Mackay
            affiliation:
                  name:MRC Toxicology Unit
                  address:
                     name:MRC Toxicology Unit, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Birmingham
                  address:
                     name:Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Moore
            affiliation:
                  name:MRC Toxicology Unit
                  address:
                     name:MRC Toxicology Unit, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Leicester
                  address:
                     name:Cancer studies, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Callum Hall
            affiliation:
                  name:Cancer Research UK Manchester Institute
                  address:
                     name:Cancer Research UK Manchester Institute, Manchester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nicolai J. Birkbak
            affiliation:
                  name:The Francis Crick Institute
                  address:
                     name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
                     type:PostalAddress
                  type:Organization
                  name:University College London Cancer Institute
                  address:
                     name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mariam Jamal-Hanjani
            affiliation:
                  name:University College London Hospitals
                  address:
                     name:Department of Medical Oncology, University College London Hospitals, London, UK
                     type:PostalAddress
                  type:Organization
                  name:Garscube Estate
                  address:
                     name:CRUK The Beatson Institute, Garscube Estate, Glasgow, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Saadia A. Karim
            affiliation:
                  name: University of Glasgow
                  address:
                     name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vinaya M. Phatak
            affiliation:
                  name:MRC Toxicology Unit
                  address:
                     name:MRC Toxicology Unit, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lucia Piñon
            affiliation:
                  name:MRC Toxicology Unit
                  address:
                     name:MRC Toxicology Unit, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jennifer P. Morton
            affiliation:
                  name: University of Glasgow
                  address:
                     name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
                     type:PostalAddress
                  type:Organization
                  name:University Hospitals Leicester NHS Trust
                  address:
                     name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charles Swanton
            affiliation:
                  name:The Francis Crick Institute
                  address:
                     name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
                     type:PostalAddress
                  type:Organization
                  name:University College London Cancer Institute
                  address:
                     name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
                     type:PostalAddress
                  type:Organization
                  name:University College London Hospitals
                  address:
                     name:Department of Medical Oncology, University College London Hospitals, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John Le Quesne
            affiliation:
                  name:MRC Toxicology Unit
                  address:
                     name:MRC Toxicology Unit, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Leicester
                  address:
                     name:Cancer studies, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University Hospitals Leicester NHS Trust
                  address:
                     name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Patricia A. J. Muller
            affiliation:
                  name:MRC Toxicology Unit
                  address:
                     name:MRC Toxicology Unit, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:Cancer Research UK Manchester Institute
                  address:
                     name:Cancer Research UK Manchester Institute, Manchester, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:9
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:MRC Toxicology Unit
      address:
         name:MRC Toxicology Unit, Leicester, UK
         type:PostalAddress
      name:University of Birmingham
      address:
         name:Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
         type:PostalAddress
      name:MRC Toxicology Unit
      address:
         name:MRC Toxicology Unit, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:Cancer studies, University of Leicester, Leicester, UK
         type:PostalAddress
      name:Cancer Research UK Manchester Institute
      address:
         name:Cancer Research UK Manchester Institute, Manchester, UK
         type:PostalAddress
      name:The Francis Crick Institute
      address:
         name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
         type:PostalAddress
      name:University College London Cancer Institute
      address:
         name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
         type:PostalAddress
      name:University College London Hospitals
      address:
         name:Department of Medical Oncology, University College London Hospitals, London, UK
         type:PostalAddress
      name:Garscube Estate
      address:
         name:CRUK The Beatson Institute, Garscube Estate, Glasgow, UK
         type:PostalAddress
      name: University of Glasgow
      address:
         name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
         type:PostalAddress
      name:MRC Toxicology Unit
      address:
         name:MRC Toxicology Unit, Leicester, UK
         type:PostalAddress
      name:MRC Toxicology Unit
      address:
         name:MRC Toxicology Unit, Leicester, UK
         type:PostalAddress
      name: University of Glasgow
      address:
         name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
         type:PostalAddress
      name:University Hospitals Leicester NHS Trust
      address:
         name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
         type:PostalAddress
      name:The Francis Crick Institute
      address:
         name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
         type:PostalAddress
      name:University College London Cancer Institute
      address:
         name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
         type:PostalAddress
      name:University College London Hospitals
      address:
         name:Department of Medical Oncology, University College London Hospitals, London, UK
         type:PostalAddress
      name:MRC Toxicology Unit
      address:
         name:MRC Toxicology Unit, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:Cancer studies, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University Hospitals Leicester NHS Trust
      address:
         name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
         type:PostalAddress
      name:MRC Toxicology Unit
      address:
         name:MRC Toxicology Unit, Leicester, UK
         type:PostalAddress
      name:Cancer Research UK Manchester Institute
      address:
         name:Cancer Research UK Manchester Institute, Manchester, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hannah L. Mackay
      affiliation:
            name:MRC Toxicology Unit
            address:
               name:MRC Toxicology Unit, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Birmingham
            address:
               name:Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
               type:PostalAddress
            type:Organization
      name:David Moore
      affiliation:
            name:MRC Toxicology Unit
            address:
               name:MRC Toxicology Unit, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Leicester
            address:
               name:Cancer studies, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:Callum Hall
      affiliation:
            name:Cancer Research UK Manchester Institute
            address:
               name:Cancer Research UK Manchester Institute, Manchester, UK
               type:PostalAddress
            type:Organization
      name:Nicolai J. Birkbak
      affiliation:
            name:The Francis Crick Institute
            address:
               name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
               type:PostalAddress
            type:Organization
            name:University College London Cancer Institute
            address:
               name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
               type:PostalAddress
            type:Organization
      name:Mariam Jamal-Hanjani
      affiliation:
            name:University College London Hospitals
            address:
               name:Department of Medical Oncology, University College London Hospitals, London, UK
               type:PostalAddress
            type:Organization
            name:Garscube Estate
            address:
               name:CRUK The Beatson Institute, Garscube Estate, Glasgow, UK
               type:PostalAddress
            type:Organization
      name:Saadia A. Karim
      affiliation:
            name: University of Glasgow
            address:
               name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
               type:PostalAddress
            type:Organization
      name:Vinaya M. Phatak
      affiliation:
            name:MRC Toxicology Unit
            address:
               name:MRC Toxicology Unit, Leicester, UK
               type:PostalAddress
            type:Organization
      name:Lucia Piñon
      affiliation:
            name:MRC Toxicology Unit
            address:
               name:MRC Toxicology Unit, Leicester, UK
               type:PostalAddress
            type:Organization
      name:Jennifer P. Morton
      affiliation:
            name: University of Glasgow
            address:
               name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
               type:PostalAddress
            type:Organization
            name:University Hospitals Leicester NHS Trust
            address:
               name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
               type:PostalAddress
            type:Organization
      name:Charles Swanton
      affiliation:
            name:The Francis Crick Institute
            address:
               name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
               type:PostalAddress
            type:Organization
            name:University College London Cancer Institute
            address:
               name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
               type:PostalAddress
            type:Organization
            name:University College London Hospitals
            address:
               name:Department of Medical Oncology, University College London Hospitals, London, UK
               type:PostalAddress
            type:Organization
      name:John Le Quesne
      affiliation:
            name:MRC Toxicology Unit
            address:
               name:MRC Toxicology Unit, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Leicester
            address:
               name:Cancer studies, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University Hospitals Leicester NHS Trust
            address:
               name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Patricia A. J. Muller
      affiliation:
            name:MRC Toxicology Unit
            address:
               name:MRC Toxicology Unit, Leicester, UK
               type:PostalAddress
            type:Organization
            name:Cancer Research UK Manchester Institute
            address:
               name:Cancer Research UK Manchester Institute, Manchester, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:MRC Toxicology Unit, Leicester, UK
      name:Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
      name:MRC Toxicology Unit, Leicester, UK
      name:Cancer studies, University of Leicester, Leicester, UK
      name:Cancer Research UK Manchester Institute, Manchester, UK
      name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
      name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
      name:Department of Medical Oncology, University College London Hospitals, London, UK
      name:CRUK The Beatson Institute, Garscube Estate, Glasgow, UK
      name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
      name:MRC Toxicology Unit, Leicester, UK
      name:MRC Toxicology Unit, Leicester, UK
      name:Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
      name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
      name:Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK
      name:Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
      name:Department of Medical Oncology, University College London Hospitals, London, UK
      name:MRC Toxicology Unit, Leicester, UK
      name:Cancer studies, University of Leicester, Leicester, UK
      name:Department of Histopathology, Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK
      name:MRC Toxicology Unit, Leicester, UK
      name:Cancer Research UK Manchester Institute, Manchester, UK

External Links {🔗}(230)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.85s.